Skip to content

Public FDA record

Z-2214-2024: Software version 5.3 in: RAPIDPoint 500e Blood Gas System (USA) Siemens Material Number: 11416751 RAPI

Recall record Z-2214-2024 for Siemens Healthcare Diagnostics Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2214-2024
Company in FDA record
Siemens Healthcare Diagnostics Inc
FDA classification date
Jun 26, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Siemens Healthineers has identified an issue with the RAPIDPoint500e system software version 5.3. This issue affects how the sample source is identified at the LIS when using the capillary mode. With this software version, samples run in the capillary mode are incorrectly labeled as arterial when displayed on the LIS, leading to the potential for results to be flagged according to an established arterial range. Capillary sample results are correctly identified as capillary on both the RAPIDPoint 500e system display and the instrument printouts. The issue only affects the new software version 5.3 and only capillary sample mode is impacted. The inability to distinguish specimen sources for blood gas may lead to incorrect diagnoses and management decisions.

Source facts

Action
Siemens Healthineers issued Urgent Medical Device Correction Letter (POC 24-015.A.US) on 5/1/7/24 to US customers via Fed'x. An Urgent Field Safety Notice (UFSN) POC 24-015.A.OUS was issued to all OUS Siemens reporting sites with affected customers for distribution and regional reporting to their local competent authorities. Letter states reason for recall, health risk and action to take: " Please review this letter with your Medical Director to determine the appropriate course of action. " Siemens will convert all RAPIDPoint 500e systems at software v5.3 to v5.2 regardless of whether the capillary sample mode is used. The software conversion will be performed by Siemens Service group. Please contact Siemens customer support for the system software conversion. " Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. " Adverse reactions or quality problems experienced with the use of the affected products listed in the above table may be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax. " Please retain this letter with your laboratory records and forward this letter to those who may have received this product. " For any questions, you may call our 24/7 Customer Service USA line at 877-229-3711.
Initiated
2024-05-17
Root cause
Software Design Change
Distribution
Worldwide - US Nationwide distribution in the states of FL, GA, LA, MI, NC and the countries of Chile, Costa Rica, France, Germany, Japan, Lebanon, Mexico, Netherlands, New Zealand, Poland, Spain, Turkey, United Kingdom.
Recall number
Z-2214-2024
Recall status
Open, Classified
CDRH record ID
208053
FDA classified
2024-06-26
Recall event number
94704

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗